Fundraising Fox
PreciseDx
New York, US · Founded 2020 · Delaware corporation · 7 known investors
Find your way into PreciseDx
Sign up to see every warm intro you have to PreciseDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PreciseDx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PreciseDx develops molecular pathology diagnostic tools for cancer care, combining anatomical pathology with molecular and systems biology to enable precise diagnosis and treatment planning. The company's flagship product serves pathologists and oncologists seeking data-driven insights for patient risk stratification and personalized cancer care.
Founders & leadership
PreciseDx was founded in 2020 by Dr. Carlos Cordon-Cardo.
DC
Dr. Carlos Cordon-CardoFounder
EC
Eric ConverseFounding Board Member - Former Interim ChairHe has previously served as CEO and board member for medical device and healthcare technology companies, and held roles in investment management representing investor interests across multiple funds.
EJ
Edward Joseph SitarChief Financial Officer
WB
Wayne BrinsterPresident and CEO2021–2024He previously served as CEO at multiple healthcare and diagnostics companies and spent over a decade in M&A and corporate development roles at Becton Dickinson.
Board
EL
Erik LiumBoard director
WD
Westley DuprayBoard director
MH
Michael Hennessy Jr.Board director
MH
Molly HarperBoard director
PR
Paul RomaBoard director
Investors · 7
Merck Global Health Innovation Fundlisted by Merck Global Health Innovation FundRahway · $10M
How we know: Merck Global Health Innovation Fund's portfolio page · prnewswire.com · Not right? Tell us
Also in the syndicate · 4
Eventide Asset ManagementleadGenHenn Capital VentureLabcorpQuest Diagnostics
Funding
SEC filings, press & company announcements$35.7M disclosed across 3 of 4 rounds · 2022–2026
- Undisclosed amountSeries A PreferredJan 2022Source ↗
▶$3.7MraisedOct 2026 · 9 investors · Other Health CareRule 506(b)
▶$3.7MraisedOct 2026 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric ConverseExecutive Officer, Director
- Molly HarperDirector
- Paul RomaDirector
- Westley DuprayDirector
- Erik LiumDirector
- Michael Hennessy Jr.Director
- Edward Joseph SitarExecutive Officer
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.2MraisedJun 2025 · 9 investors · Other Health CareRule 506(b)
▶$11.2MraisedJun 2025 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Erik LiumDirector
- Westley DuprayDirector
- Michael Hennessy Jr.Director
- Paul RomaDirector
- Molly HarperDirector
- Eric ConverseExecutive Officer, Director
- Edward Joseph SitarExecutive Officer
- Offering amount
- $15M
- Amount sold
- $11.2M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$20.7MraisedApr 2024 · 10 investors · Other Health CareRule 506(b)
▶$20.7MraisedApr 2024 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Erik LiumDirector
- Eric ConverseDirector
- Wayne BrinsterExecutive Officer, Director
- Molly HarperDirector
- Westley DuprayDirector
- Offering amount
- $28.2M
- Amount sold
- $20.7M
- Sales commissions
- $800K
- Placement agents
- Aquilo Partners, L.P.
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
PreciseMDXPreciseMDX offers an AI-driven platform for clinical and diagnostic laboratories that digitizes and automates lab order intake, converting handwritten requisitions, insurance cards, and IDs into structured data. It handles order management, verifies physician signatures, cross-maps lab codes, and provides analytics to reduce manual data entry and errors.
ItnonlineImaging Technology News is a trade publication that reaches over 34,000 radiology, radiation oncology, women's health, and nuclear medicine professionals with editorial content and product comparison tools. The publication serves as a primary resource for healthcare technology purchasing decisions within medical imaging specialties.
Predictive OncologyPredictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.
PrecisionPrecision is an AI platform paired with operators who build, train, and run AI agents across a company's marketing, delivery, support, operations, and finance functions. It targets professional, recurring-revenue businesses of 10-50 people (consultancies, coaches, agencies, recruiters, and software companies), installing and managing agents for them rather than leaving setup to DIY.
Companies working in the same space as PreciseDx.
In the news
Frequently asked questions
- What does PreciseDx do?
- PreciseDx develops molecular pathology diagnostic tools for cancer care, combining anatomical pathology with molecular and systems biology to enable precise diagnosis and treatment planning. The company's flagship product serves pathologists and oncologists seeking data-driven insights for patient risk stratification and personalized cancer care.
- Who founded PreciseDx?
- PreciseDx was founded by Dr. Carlos Cordon-Cardo in 2020.
- Who are PreciseDx's investors?
- PreciseDx's investors include Merck Global Health Innovation Fund, MSD Global Health Innovation Fund, Philips Ventures.
- How much funding has PreciseDx raised?
- PreciseDx has disclosed $35.7M raised across 3 of its 4 known rounds.
- Where is PreciseDx headquartered?
- PreciseDx is headquartered in New York, US.